ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Contact Contact UsBy Biotech Metropolitan WomenMay 27, 2020[contact-form-7 id=”63602″ title=”Contact Us”] Read More
